Medicalgorithmics Stock

Medicalgorithmics EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Medicalgorithmics (MDG.WA) as of Jul 12, 2026 is -23.69. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 595.00 — a change of -103.98% (lower).

EV/EBIT

-23.69

YoY

-103.98%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Medicalgorithmics is 2026 -23.69 . EV/EBIT (Enterprise Value to EBIT) of Medicalgorithmics was 2025 595.00 . It decreases by -103.98% lower compared to the previous year.

The Medicalgorithmics EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2019
0.00 base
Jan 1, 2020
-2.44 base
Jan 1, 2021
7.10 base
Jan 1, 2022
4.36 base
Jan 1, 2023
0.00 base
Jan 1, 2024
-12.13 base
Jan 1, 2025 (e)
-32.73 base
Jan 1, 2026 (e)
55.21 base
YEARPRICE-TO-EBIT
2026 est 55.21
2025 est -32.73
2024 -12.13
2023 -
2022 4.36
2021 7.10
2020 -2.44
2019 -
2018 3.75
2017 17.21
2016 58.87
2015 36.23
2014 47.01
2013 26.64
2012 26.96
2011 17.27
Access this data via the Eulerpool API
Get Free API Key

Medicalgorithmics Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Medicalgorithmics's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Medicalgorithmics's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Medicalgorithmics's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Medicalgorithmics grows earnings faster than its peers.

Medicalgorithmics Stock analysis

What does Medicalgorithmics do? Medicalgorithmics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medicalgorithmics stock

EV/EBIT (Enterprise Value to EBIT) of Medicalgorithmics is -23.69 in 2026.

Access this data via the Eulerpool API
Get Free API Key

Valuation — Medicalgorithmics

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueEV/EBITForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Medicalgorithmics